Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 1711 AL 1725

Therapeutic Effects of the major alkaloid constituents of Evodia rutaecarpa in Alzheimer's disease

Cao Q, Dong P, Han H.

Psychogeriatrics. 2024 Mar;24(2):443-457. doi: 10.1111/psyg.13051. Epub 2024 Jan 3.

Role of Artificial Intelligence in Multinomial Decisions and Preventative Nutrition in Alzheimer's Disease

Soares Dias Portela A, Saxena V, Rosenn E, Wang SH, Masieri S, Palmieri J, Pasinetti GM.

Mol Nutr Food Res. 2024 Jul;68(13):e2300605. doi: 10.1002/mnfr.202300605. Epub 2024 Jan 4.

Peripheral blood amyloid-β involved in the pathogenesis of Alzheimer's disease via impacting on peripheral innate immune cells

Shi M, Chu F, Zhu F, Zhu J.

J Neuroinflammation. 2024 Jan 4;21(1):5. doi: 10.1186/s12974-023-03003-5.

Radiotherapy for non-cancer diseases: benefits and long-term risks

Thariat J, Little MP, Zablotska LB, Samson P, O'Banion MK, Leuraud K, Bergom C, Girault G, Azimzadeh O, Bouffler S, Hamada N.

Int J Radiat Biol. 2024;100(4):505-526. doi: 10.1080/09553002.2023.2295966. Epub 2024 Jan 5.

Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease

Vance JM, Farrer LA, Huang Y, Cruchaga C, Hyman BT, Pericak-Vance MA, Goate AM, Greicius MD, Griswold AJ, Haines JL, Tcw J, Schellenberg GD, Tsai LH, Herz J, Holtzman DM.

Ann Neurol. 2024 Apr;95(4):625-634. doi: 10.1002/ana.26864. Epub 2024 Jan 5.

The function of sphingolipids in different pathogenesis of Alzheimer's disease: A comprehensive review

Wang X, Li H, Sheng Y, He B, Liu Z, Li W, Yu S, Wang J, Zhang Y, Chen J, Qin L, Meng X.

Biomed Pharmacother. 2024 Feb;171:116071. doi: 10.1016/j.biopha.2023.116071. Epub 2024 Jan 6.

Cell type-specific roles of APOE4 in Alzheimer disease

Blumenfeld J, Yip O, Kim MJ, Huang Y.

Nat Rev Neurosci. 2024 Feb;25(2):91-110. doi: 10.1038/s41583-023-00776-9. Epub 2024 Jan 8.

Data-driven modelling of neurodegenerative disease progression: thinking outside the black box

Young AL, Oxtoby NP, Garbarino S, Fox NC, Barkhof F, Schott JM, Alexander DC.

Nat Rev Neurosci. 2024 Feb;25(2):111-130. doi: 10.1038/s41583-023-00779-6. Epub 2024 Jan 8.

How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer's disease?

Beveridge J, Kaniecki E, Naidu A, Silverglate BD, Grossberg G.

Expert Opin Emerg Drugs. 2024 Mar;29(1):35-43. doi: 10.1080/14728214.2024.2304059. Epub 2024 Jan 12.

Neuronal and glial vulnerability of the suprachiasmatic nucleus in tauopathies: evidence from human studies and animal models

Son G, Neylan TC, Grinberg LT.

Mol Neurodegener. 2024 Jan 10;19(1):4. doi: 10.1186/s13024-023-00695-4.

Agents at the Peak of US FDA Approval for the Treatment of Alzheimer's Disease

Alam J, Kalash A, Hassan MI, Rahman SZ.

Neurol Res. 2024 Apr;46(4):318-325. doi: 10.1080/01616412.2024.2302271. Epub 2024 Jan 10.

Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer's Disease

Drakontaeidi A, Pontiki E.

Int J Mol Sci. 2024 Jan 1;25(1):582. doi: 10.3390/ijms25010582.

Targeting misfolding and aggregation of the amyloid-β peptide and mutant p53 protein using multifunctional molecules

Grcic L, Leech G, Kwan K, Storr T.

Chem Commun (Camb). 2024 Feb 1;60(11):1372-1388. doi: 10.1039/d3cc05834d.

Potential links between platelets and amyloid-β in the pathogenesis of Alzheimer's disease: Evidence from in vitro, in vivo, and clinical studies

Yubolphan R, Pratchayasakul W, Koonrungsesomboon N, Chattipakorn N, Chattipakorn SC.

Exp Neurol. 2024 Apr;374:114683. doi: 10.1016/j.expneurol.2024.114683. Epub 2024 Jan 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias